Werewolf Therapeutics Inc (HOWL)
2.44
-0.07
(-2.79%)
USD |
NASDAQ |
Jun 28, 16:00
2.400
-0.04
(-1.64%)
After-Hours: 20:00
Werewolf Therapeutics Total Liabilities (Quarterly): 60.01M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 60.01M |
| December 31, 2023 | 63.46M |
| September 30, 2023 | 63.94M |
| June 30, 2023 | 66.64M |
| March 31, 2023 | 74.00M |
| December 31, 2022 | 37.91M |
| September 30, 2022 | 41.48M |
| Date | Value |
|---|---|
| June 30, 2022 | 45.49M |
| March 31, 2022 | 25.31M |
| December 31, 2021 | 26.46M |
| September 30, 2021 | 9.072M |
| June 30, 2021 | 8.862M |
| March 31, 2021 | 243.19M |
| December 31, 2020 | 148.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.862M
Minimum
Jun 2021
243.19M
Maximum
Mar 2021
65.29M
Average
52.75M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.581M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.60M |
| Shareholders Equity (Quarterly) | 117.59M |
| Debt to Equity Ratio | 0.3352 |
| Current Ratio | 6.707 |
| Net Debt Paydown Yield | -2.81% |